
==== Front
J Health Econ Outcomes Res
J Health Econ Outcomes Res
1694
Journal of Health Economics and Outcomes Research
2326-697X
2327-2236
Columbia Data Analytics, LLC Website: Journal of Health Economics and Outcomes Research

36945240
70252
10.36469/001c.70252
Cardiovascular Conditions
Cardiovascular Disease and Its Implication for Higher Catastrophic Health Expenditures Among Households in Sub-Saharan Africa
Adeniji Folashayo Ikenna Peter 1
Obembe Taiwo Akinyode 1
1 Department of Health Policy & Management, Faculty of Public Health, College of Medicine University of Ibadan, Ibadan, Nigeria
Corresponding author: Email address: folashayoadeniji@yahoo.co.uk
17 3 2023
2023
10 1 5967
19 1 2023
7 2 2023
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Background: Cardiovascular diseases (CVDs) impose an enormous and growing economic burden on households in sub-Saharan Africa (SSA). Like many chronic health conditions, CVD predisposes families to catastrophic health expenditure (CHE), especially in SSA due to the low health insurance coverage. This study assessed the impact of CVD on the risks of incurring higher CHE among households in Ghana and South Africa. Methods: The World Health Organization (WHO) Study on Global AGEing and Adult Health (WHO SAGE), Wave 1, implemented 2007-2010, was utilized. Following standard procedure, CHE was defined as the health expenditure above 5%, 10%, and 25% of total household expenditure. Similarly, a 40% threshold was applied to household total nonfood expenditure, also referred to as the capacity to pay. To compare the difference in mean CHE by household CVD status and the predictors of CHE, Student’s t-test and logistic regression were utilized. Results: The share of medical expenditure in total household spending was higher among households with CVD in Ghana and South Africa. Households with CVD were more likely to experience greater CHE across all the thresholds in Ghana. Households who reported having CVD were twice as likely to incur CHE at 5% threshold (odds ratio [OR], 1.946; confidence interval [CI], 0.965-1.095), 3 times as likely at 10% threshold (OR, 2.710; CI, 1.401-5.239), and 4 times more likely to experience CHE at both 25% and 40% thresholds, (OR, 3.696; CI, 0.956-14.286) and (OR, 4.107; CI, 1.908-8.841), respectively. In South Africa, households with CVD experienced higher CHE across all the thresholds examined compared with households without CVDs. However, only household CVD status, household health insurance status, and the presence of other disease conditions apart from CVD were associated with incurring CHE. Households who reported having CVD were 3 times more likely to incur CHE compared with households without CVD (OR, 3.002; CI, 1.013-8.902). Conclusions: Our findings suggest that CVD predisposed households to risk of higher CHE. Equity in health financing presupposes that access to health insurance should be predicated on individual health needs. Thus, targeting and prioritizing the health needs of individuals with regard to healthcare financing interventions in SSA is needed.

cardiovascular disease
catastrophic health expenditure
universal health coverage
chronic noncommunicable diseases
sub-Saharan Africa
This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (grant No. G-19-57145), Sida (grant No. 54100113), Uppsala Monitoring Center, Norwegian Agency for Development Cooperation (Norad), and by the Wellcome Trust [reference No. 107768/Z/15/Z] and the UK Foreign, Commonwealth & Development Office, with support from the Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) program. The statements made and views expressed are solely the responsibility of the Fellow.
==== Body
pmcBACKGROUND

Cardiovascular diseases (CVDs) are defined as a group of heart and blood vessel–related disorders.1 Examples of CVDs include cerebrovascular disease, hypertension, congenital heart disease, myocardial infarction, coronary artery disease or angina pectoris, rheumatic heart disease, cardiac arrhythmias, peripheral vascular disease (aneurysms and peripheral arterial disease), valvular heart disease, and congestive heart failure.2 These diseases impose an enormous and growing economic burden on individuals and households in developing countries. Research has shown that CVDs manifest about 10 to 15 years earlier in low- and middle-income countries (LMICs) when compared with developed countries.3 This earlier onset could lead to a reduction in the productive/working-age population, with serious implications for the economies of these countries.4

In particular, CVDs caused twice the number of deaths related to HIV, malaria, and tuberculosis combined in LMICs from the review of changes in mortality between 1990 and 2001.5 The Global Burden of Disease study estimated that CVDs caused almost 6.4 million deaths of people aged 30 to 69 years in developing countries in 2020.6 Another study estimated that 15.9 million potential productive years of life lost were lost in India and China in 2000 due to CVDs7 and about 2.5 billion, 237 billion, and 558 billion in 1998 International dollars lost in the gross domestic product in Tanzania, India, and China, respectively, between 2005 and 2015.7 As such, reducing morbidity and mortality due to CVDs remains at the center of public discourse and population health priorities in LMICs.8

Epidemiology of CVD in Sub-Saharan Africa

According to the World Health Organization (WHO) Global Burden of Disease Study, CVD is one of the leading causes of morbidity and mortality in sub-Saharan Africa (SSA), with high systolic blood pressure accounting for 56.6% of disability-adjusted life-years in 2021.9 The number of deaths due to these diseases increased by 50% between 1990 and 2019 in SSA.10 In 2019 alone, CVDs caused nearly 1 million deaths in SSA, contributing about 4.5% of all CVD-related mortality globally.11

Although research evidence suggests few cases of CVDs were recorded in SSA before the 1990s, its prevalence has been increasing in the last 3 decades.12 According to studies conducted in some SSA countries, the emerging public and population health problems posed by CVDs in the subregion can be attributed to aging, rapid urbanization, demographic transition, lifestyle change, and a high prevalence of common risk factors such as hypertension, tobacco use, abdominal obesity, physical inactivity (sedentary lifestyle), alcohol misuse, and diabetes.13 In the INTERHEART Africa study,13 the 5 CVD risk factors modeled in the study were estimated to account for population attributable risk of 90% for acute myocardial infarction. In particular, current and former tobacco use, hypertension, and diabetes were revealed as the risk factors with the highest influence on the odds of a patient suffering a cardiovascular event in the Black African population. Simply put, these risk factors account for the largest percentage of the economic burden of CVD in SSA. The study suggests that the failure to control or prevent risk factors and risk behaviors will have a substantial impact on the economic burden of CVDs in Africa compared with the rest of the world in the near future.13

Some research evidence has shown that several other factors contribute to the risk of CVD events. For instance, higher-income Black Africans were more predisposed to myocardial infarction compared with Whites and non-Black Africans of similar economic status.13 The effects of the prevalence of HIV/AIDS has been linked to generating other CVDs such as rheumatic valvular and cardiomyopathy, which manifests in the form of tuberculous pericarditis.14

In particular, many countries in SSA are experiencing an increase in the prevalence of chronic diseases like CVD.15 For example, Nigeria is the most populous country in SSA, and CVDs represent a growing public health threat in the country. According to WHO estimates of the burden of noncommunicable diseases globally, CVDs were responsible for about 7% of deaths in Nigeria in 2014 alone.16 Similarly, several subpopulation studies have revealed that hypertensive heart failure contributes the largest burden of CVDs in Nigeria, constituting nearly 61% of all CVD cases in the country.

The Institute for Health Metrics and Evaluation reported that mortality as a result of stroke and ischemic heart disease increased by 10.6% and 14.6%, respectively, in Ghana between 2007 and 2017. In terms of the risk factors that contributed to disabilities in the same period, diabetes increased by 52.8% while the deaths and disabilities caused by high blood pressure increased by 17.0%.17 In South Africa, reports show that CVD is second only to HIV/AIDS in terms of the number of deaths caused. This disease condition accounts for almost 17.3% of adult deaths in the country, and more South Africans die as a result of CVDs than of all cancers.18

More importantly, given the weak insurance infrastructure in many SSA countries, CVDs have implications for higher catastrophic health expenditures (CHE), especially among economically less viable households. Compared with developed countries and most other developing regions of the world, SSA countries allocate significantly lower funds (as a percentage of gross domestic product) to providing healthcare services.18 A systematic review of public financing of healthcare services in developing countries between 1995 and 2006 revealed that while the share of government spending on health increased in most regions, it decreased in SSA countries.19 Also, a WHO report on health spending and disease burden in Africa indicated that healthcare remains underfunded in the region. As of 2015, only 6 SSA countries (Liberia, Madagascar, Malawi, Rwanda, Togo, and Zambia) have met the target of 15% of annual national budget set at the Abuja Declaration of 2001. (The Declaration has been used to refer to the conference held in Abuja, the federal capital territory of Nigeria, where all the members of African Union met and pledged to allocate ≥15% of the national budget to the healthcare sector yearly.) Consequently, individuals and households in SSA are often predisposed to incurring substantial CHE due to high out-of-pocket (OOP) payments for medical services.20 For the 2 countries used as case studies, a recent study reported that only 13.3% of the South African population had health insurance,21 while another study reported poor coverage of the National Health Insurance Scheme in Ghana,22 which means that the progress in terms of universal health coverage (UHC) has been marginal in the last decade in both countries and, indeed, in many SSA countries.

The extent of CHE experienced by individuals and households vary according to health needs (especially for chronic health conditions like CVD) and the availability of effective financial protection mechanism. Earlier studies in SSA have investigated the incidence of CHE in the general population. By extension, this study examined the differentials in the experience of CHE among households with and without CVD using data from 2 SSA countries, Ghana and South Africa. Evidence in the literature reveals that these countries are in various stages in terms of realizing UHC as articulated in the Sustainable Development Goals. Moreover, both countries have yet to provide adequate financial protection that covers the entire population.23 The implication is that the policy on affordable healthcare through social health insurance has yet to attain its optimal potential in both countries. Therefore, this study is warranted to examine the differentials in the experience of CHE among households with and without CVDs in these 2 countries. Findings from this study will provide evidence-based recommendations to support policies toward UHC in both countries and in other similar countries in SSA.

METHODS

Data Source

This study utilized data drawn from the WHO Study on Global AGEing and Adult Health (WHO SAGE), Wave 1, which was carried out between 2007 and 2010. This survey is a nationally representative study implemented in 6 countries: China, Ghana, India, Mexico, Russia, and South Africa. Only the 2 SSA countries covered in the survey were included in this study. The WHO SAGE, Wave 1 sampled 5110 and 4223 adults 50 years and older in Ghana and South Africa, respectively. Also, the study survey sampled a smaller comparative sample of adults 18 to 49 years of age. The study combined household-level and individual-level modules to collect important data sets. The household-level module was used to elicit information such as household healthcare demand and utilization, access to medical insurance, broad categories of household spending, including health expenditure, and household permanent income. The expenditure categories elicited in the data include monthly expenditure on food items; housing and utility; clothing, transportation, recreation, and entertainment; and total monthly healthcare spending. Expenditures on education, durable goods, vehicles, cost of hospitalization, and amount paid on insurance premiums were elicited on an annual basis. Similarly, the individual-level module was used to collect data on variables such as sociodemographics, health risk behavior, and health state description. In the data set, household health expenditure aggregated the monetary outlay toward the outpatient care received from physicians and nurses, purchase of medicines/drugs, diagnostic and laboratory tests, traditional or alternative care, costs associated with hospitalizations, and other medical-related costs. The health conditions covered in the data included arthritis, stroke, angina or angina pectoris, chronic lung cancer, asthma, depression, hypertension, cataracts, oral health, injuries, and cervical and breast cancer (for women only). Based on the standard classification of diseases, angina and hypertension are the 2 CVD conditions captured in the data. Therefore, these 2 heart-related conditions were utilized as CVDs for the purpose of data analysis.

Measure of Catastrophic Health Expenditure

The conceptualization of CHE relates to medical spending above a predetermined threshold, in relation to household income, that often causes financial distress for individuals and households. This study favored the use of household expenditure as a measure of household income and thus as a proxy for household economic well-being. This is because consumption expenditure is less affected by short-term fluctuations and better reflects the welfare of households.24 Therefore, in this study, CHE is defined as the medical expenditure above 5%, 10%, and 25% of household total expenditure. Similarly, a 40% threshold was applied to household total nonfood expenditure, which has also been widely utilized in the literature. Household expenditure categories were adjusted for household composition and size. Thus, the level of CHE among households was implemented as follows:

CHE=Heheor(he−hfex)≥z%

where He = total household health expenditure, he = total household expenditure, hfex = total household food expenditure, he−hfex = capacity to pay/discretionary income, and z% = the predetermined thresholds (which are 5%, 10%, 25%, and 40%, depending on the denominator). To adjust for household size, all expenditure categories were divided by the respective household size to generate per capita expenditure categories. The share of health expenditure in household budget was expressed as:

(Total Household Health Expenditure(He)Total Household Expenditure(he))×100

Data Analysis

For comparison purposes, households were classified by their CVD status (ie, whether a member or members of the household reported having CVD. The data from both countries were analyzed independently, and the results were compared accordingly. Descriptive statistics were utilized to report categorical variables, and the mean and SD of continuous variables were presented. To measure the CHE among households, the standard procedures adopted in previous studies was used.25,26 All expenditure categories were annualized. To compare the difference in mean CHE by household CVD status and the predictors of CHE, Student’s t-test and logistic regression were utilized. The logistic regression model is given as:

π1−π=exp(β0+β1X1+…+βkXk),

where π ∕ 1 − π is the probability for the event of CHE (ie, the outcome variable) and X1 represents the explanatory/predictor variables. Important risk factors for CVD were identified from literature reviews and were included in the logistic regression model as X1. All predictors were included and retained. A sensitivity analysis, using different thresholds of CHE, was then used to determine what variables are significant at different thresholds. All the data were analyzed using Stata version 15 (StataCorp, College Station, Texas).

Predictor Variables

The covariates controlled for in the model include sex, age, and education of household head; tobacco use; alcohol use; CVD status; household access to health insurance; number of fruit servings; number of vegetable servings; daily vigorous physical activity; household per capita expenditure; household size; and presence of other non-CVD health conditions such as the presence of cervical and breast cancers (for women), arthritis, stroke, chronic lung disease, asthma, depression, cataracts, oral health, and injuries. A dummy variable was introduced in the regression model such that 1 (Yes) represented the presence of 1 or more of the non-CVD health conditions captured in the data; and 0 (No) for households who did not report any of the non-CVD conditions. The number of fruits and vegetable servings were captured per day and per year, while vigorous physical activities were captured per day and per week. Weekly and monthly data were annualized for data analysis. Covariates such as sociodemographic characteristics, tobacco use, alcohol use, number of fruit servings, number of vegetable servings, and daily vigorous physical activity were included in the model because they have been strongly associated with increasing or reducing the risks of CVDs and other chronic noncommunicable diseases apart from other nonmodifiable risk factors like age and family history.27,28 The intuition is that when an individual engages in a risky health behavior and falls ill as a result, there is a tendency that the individual could incur CHE due to increased demand for healthcare services. Although indirect, the path from risky health behavior to CHE affects the demand for healthcare services.

RESULTS

Table 1 depicts the sociodemographic characteristics of households by CVD status in Ghana and South Africa. Data on 3938 individuals sampled in Ghana and 2400 persons sampled in South Africa were analyzed. In both countries, the mean age in households with CVD (Ghana, 49.28 ± 17.84 years; South Africa, 48.96 ± 15.85 years) was higher compared with households without CVD (Ghana, 40.66 ± 16.46 years; South Africa, 35.90 ± 13.25 years). There were more males relative to females who had CVD (147 [74.62] in Ghana and 187 [67.03%] in South Africa). These figures also indicate that the prevalence of CVD is relatively higher in the latter country. Similarly, a higher proportion of respondents who were currently married had CVD in both countries, 128 (64.97%) and 142 (50.90%), respectively. The level of access to health insurance reported among households was generally low. Among households without CVD, the majority (96.87% and 88.87% in both countries, respectively) reported not having access to health insurance. Likewise, in Ghana, 95.83% of households with member(s) with CVD had no access to financial protection in the form of health insurance. Also, in South Africa, only 10.66% of households with CVD reported having access to health insurance. Access to health insurance is slightly higher in South Africa than in Ghana.

152433 Table 1. Sociodemographic Variables by CVD Status in Ghana and South Africa (WHO SAGE, Wave 1)

Variable	Ghana, n (%)	South Africa, n (%)	
No CVD	CVD	Total	No CVD	CVD	Total	
Age (y)	40.66 (45.21)	49.28 (54.79)	44.97a (100.00)	35.90 (42.32)	48.96 (57.70)	42.43a (100.00)	
Education (y)	6.10 (54.61)	5.07 (45.39)	6.03a (100.00)	8.95 (5.57)	6.84 (6.01)	8.65a (100.00)	
Sex	
Male	1468 (53.25)	147 (74.62)	1615 (54.61)	1001 (50.89)	187 (67.03)	1236 (52.57)	
Female	1289 (46.75)	50 (25.38)	1339 (45.39)	966 (49.11)	92 (32.97)	1115 (47.43)	
Marital status	
Never married	576 (20.92)	20 (10.15)	596 (20.31)	972 (49.49)	67 (24.01)	1094 (46.59)	
Currently married	1618 (58.75)	128 (64.97)	1746 (59.07)	723 (36.81)	142 (50.90)	899 (38.29)	
Cohabiting	74 (2.69)	5 (2.54)	79 (2.67)	27 (1.37)	2 (0.72)	31 (1.32)	
Separated/divorced	196 (7.12)	15 (7.61)	211 (7.18)	56 (2.85)	14 (5.02)	71 (3.02)	
Widowed	249 (9.03)	29 (14.72)	278 (9.36)	93 (4.74)	43 (15.41)	144 (6.13)	
Unknown	41 (1.49)	—	41 (1.40)	93 (4.74)	11 (3.94)	109 (4.64)	
Health insurance	
No	1947 (96.87)	138 (95.83)	2205 (96.50)	1621 (88.87)	243 (89.34)	2192 (89.51)	
Yes	63 (3.13)	6 (4.17)	69 (3.50)	203 (11.13)	29 (10.66)	257 (10.49)	
Age, education, sex, and marital status are strictly that of the household head. Abbreviation: CVD, cardiovascular disease.

aMean age and education of the total sample, in years.

Tobacco use, alcohol misuse, low fruit and vegetable intake, and inadequate physical activity are among the major risk factors for CVD. Table 2 shows the summary of common risk factors for CVD among households in the 2 SSA countries. The prevalence of tobacco use in South Africa (73.84%) is very high compared with Ghana (7.48%). However, more households reported alcohol consumption in Ghana (45.31%) than South Africa (29.77%). Similarly, the percentage of households that consumed tobacco and reported having CVD in Ghana (6.34%) is lower relative to that of South Africa (14.28%). The mean fruit and vegetable servings among households with CVD (4.02 and 3.06) is higher than that among households without CVD (3.90 and 2.51). In South Africa, the average number of fruit servings among households with CVD (1.96) is also higher relative to households without CVD (1.88). In both countries, households without CVDs had greater rigorous physical activity on average.

152434 Table 2. Risk Factors for CVD in Ghana and South Africa (WHO SAGE, Wave 1)

Risk Factor		Ghana			South Africa		
	No CVD	CVD	Total	No CVD	CVD	Total	
Tobacco use, n (%)							
No	2535 (92.52)	184 (93.4)	2752 (92.6)	515 (26.3)	73 (26.16)	627 (26.9)	
Yes	205 (7.48)	13 (6.6)	220 (7.4)	1443 (73.7)	206 (73.84)	1704 (73.1)	
Alcohol use, n (%)							
No	1499 (54.69)	106 (53.81)	1626 (54.69)	1373 (70.23)	192 (68.82)	1628 (69.96)	
Yes	1242 (45.31)	91 (46.19)	1347 (45.31)	582 (29.77)	87 (31.18)	699 (30.04)	
No. of fruit servings, mean (SD); range	3.90 (4.01);
0.00-50.00	4.02 (4.36);
0.00-40.00	3.91 (4.08);
0.00-50.00	1.88 (1.57)
0.00-12.00	1.96 (1.98);
0.0-21.00	1.87 (1.63);
0.00, 21.00	
No. of vegetable servings, mean (SD); range	2.51 (1.92);
0.00-50.00	3.06 (3.91);
0.00-50.00	2.55 (2.11);
0.00-50.00	1.96 (1.53);
0.00-12.00	1.95 (1.53);
0.00-12.00	1.96 (1.61);
0.00-21.00	
Vigorous physical activities, mean (SD); range	2.510 (2.700);
0-7	1.363 (2.310);
0-7	2.431 (2.691);
0-7	1.099 (1.940);
0-7	0.743 (1.604);
0-7	1.036 (1.891);
0-7	
Abbreviation: CVD, cardiovascular disease.

The mean share of health expenditure in relation to household expenditure by CVD status is shown in Table 3. This share was calculated using total household expenditure and total household nonfood expenditure or capacity to pay, respectively. The share of medical expenditure in household expenditure and nonfood expenditure was higher among with CVD patients in Ghana. Likewise, in South Africa, the share of health spending in total expenditure was similar across households irrespective of whether the household had CVD. Nonetheless, the share of medical expenditure with respect to total household nonfood expenditure was higher among households with CVD in South Africa.

152435 Table 3. Health Expenditure Share of Total Household Expenditure in Ghana and South Africa (WHO SAGE, Wave 1)

		Ghana			South Africa		
	No CVD (n = 2098)	CVD
(n = 158)	Total
(n = 2394)	No CVD (n = 1325)	CVD
(n = 192)	Total
(n = 1775)	
Share of total household expenditure, mean (SD); range	0.04 (0.06);
0.00, 0.63	0.06 (0.09);
0.00, 0.49	0.040.07;
(0.00, 0.87)	0.02 (0.06);
0.00, 0.78	0.02 (0.07);
0.00, 0.47	0.02 (0.06);
0.00, 0.78	
Share of total household nonfood expenditure, mean (SD); range	0.11 (0.15);
0.00, 0.89	0.17 (0.22);
0.00, 0.95	0.12 (0.16);
0.00, 0.96	0.03 (0.10);
0.00, 0.94	0.04 (0.12);
0.00, 0.78	0.03 (0.10);
0.00, 0.94	
Abbreviation: CVD, cardiovascular disease.

Table 4 shows the CHE head count by household CVD status in the 2 countries. The level of CHE among households in both countries was higher with the 5% threshold compared with the 10%, 25%, and 40% thresholds. In Ghana and at the 5% threshold, the level of CHE was 27.78% among households without CVD relative to 37.34% among households with CVD. At the 10% threshold, more households with CVDs (24.05%) incurred CHE relative to those without CVD (12.39%) in Ghana. This trend was consistent for other thresholds. Also in South Africa, households that reported having a member with CVD experienced higher CHE across all the thresholds examined compared with households without CVD.

152436 Table 4. Catastrophic Health Expenditures by CVD Status Among Households (WHO SAGE, Wave 1)

CHE Threshold Level	Ghana	South Africa	
No CVD	CVD	Total	No CVD	CVD	Total	
5%, n (%)	
No	1516 (72.22)	99 (62.66)	1615 (71.56)	1202 (90.72)	172 (89.58)	1374 (90.57)	
Yes	583 (27.78)	59 (37.34)	642 (28.44)	123 (9.28)	20 (10.42)	143 (9.43)	
10%, n (%)	
No	1839 (87.61)	120 (75.95)	1959 (86.80)	1257 (94.87)	180 (93.75)	1437 (94.73)	
Yes	260 (12.39)	38 (24.05)	298 (13.20)	68 (5.13)	12 (6.25)	80 (5.27)	
25%, n (%)	
No	2057 (98.00)	150 (94.94)	2207 (97.78)	1304 (98.42)	186 (96.88)	1490 (98.22)	
Yes	42 (2.00)	8 (5.06)	50 (2.22)	21 (1.58)	6 (3.13)	27 (1.78)	
40%, n (%)	
No	1933 (92.09)	135 (85.44)	2068 (91.63)	1297 (97.89)	186 (96.88)	1483 (97.76)	
Yes	166 (7.91)	23 (14.56)	189 (8.37)	28 (2.11)	6 (3.13)	34 (2.24)	
Abbreviations: CHE, catastrophic health expenditure; CVD, cardiovascular disease.

The difference in mean CHE is compared among households by CVD status as shown in Table 5. In Ghana, estimates show that households who reported having CVD significantly incurred CHE compared with households without CVD for all the thresholds. There is a similar pattern for households in South Africa, although it was significant only for the 25% threshold. For the 5%, 10%, 25%, and 40% thresholds, households with CVD incurred about 9%, 11%, 3%, and 6% higher CHE, respectively, relative to the comparison group in Ghana. However, in South Africa, this difference is less evident, except for the 25% threshold, where households with CVD incurred roughly 2% higher CHE compared with households without CHE.

152437 Table 5. Student’s t-Test Results Comparing the Difference in Mean CHE by CVD Status (WHO SAGE, Wave 1)

CHE Threshold Level	Ghana	South Africa	
Estimated Difference (SE)	95% CI	Estimated Difference (SE)	95% CI	
5%	-0.096a (0.037)	-0.168, -0.023	-0.011 (0.023)	-0.056, 0.033	
10%	-0.1166a (0.028)	-0.171, -0.062	-0.011 (0.017)	-0.045, 0.023	
25%	-0.031a (0.012)	-0.054, -0.007	-0.015b (0.010)	-0.035, 0.005	
40%	-0.066a (0.022)	-0.111, -0.02	-0.010 (0.011)	-0.033, 0.012	
Abbreviations: CHE, catastrophic health expenditure; CI, confidence interval; CVD, cardiovascular disease; SE, standard error.

aSignificant at P < .01.

bSignificant at P < .1.

Table 6 depicts the factors associated with the experience of CHE among households with and without CVD. In Ghana, sex, age, CVD status, engagement in daily vigorous activity, household per capita expenditure, and household size were associated with CHE across all the thresholds. For instance, households with CVD were more likely to experience greater CHE across all the thresholds examined in Ghana. Households who reported having CVD were twice as likely to incur CHE at the 5% threshold (OR, 1.946; CI, 0.965-1.095), 3 times more likely at 10% threshold (OR, 2.710; CI, 1.401-5.239), and 4 times more likely to experience CHE at both 25% and 40% thresholds (OR, 3.696; CI, 0.956-14.286), and (OR, 4.107; CI, 1.908-8.841), respectively. In South Africa, only household CVD status, household health insurance status, and the presence of other disease conditions apart from CVD were associated with incurring CHE. Households who reported having CVD were 3 times more likely to incur CHE than households without CVD (OR, 3.002; CI, 1.013-8.902).

152438 Table 6. Factors Associated With CHE Among Households With and Without CVD in Ghana and South Africa (WHO SAGE, Wave 1)

	CHE Threshold Level: Ghana	CHE Threshold Level: South Africa	
5%	10%	25%	40%	5%	10%	25%	40%	
OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	OR (SE)	95% CI	
Sex	1.070 (0.168)	0.786-1.457	1.399 (0.305)	0.912-2.145	2.998b (1.610)	1.046-8.589	2.274c (0.596)	1.361-3.801	0.998 (0.211)	0.660-1.509	0.985 (0.274)	0.571-1.697	1.842 (0.849)	0.747-4.544	1.397 (0.563)	0.634-3.078	
Age (y)	1.742c (0.352)	1.172-2.590	1.321 (0.354)	0.781-2.233	0.792 (0.449)	0.261-2.406	0.895 (0.303)	0.461-1.739	0.814 (0.219)	0.480-1.381	1.185 (0.385)	0.627-2.242	0.951 (0.509)	0.333-2.715	1.339 (0.608)	0.550-3.261	
Education (y)	0.908 (0.136)	0.678-1.217	1.187 (0.245)	0.792-1.779	1.233 (0.656)	0.434-3.500	1.017 (0.255)	0.622-1.663	0.700a (0.130)	0.486-1.008	0.677a (0.144)	0.447-1.026	1.206 (0.449)	0.581-2.504	1.156 (0.354)	0.634-2.105	
Tobacco use	1.072 (0.086)	0.917-1.254	1.030 (0.108)	0.838-1.266	1.197 (0.353)	0.671-2.135	1.307 (0.253)	0.894-1.910	0.895 (0.228)	0.543-1.476	0.699 (0.233)	0.364-1.344	0.377 (0.267)	0.094-1.511	0.543 (0.283)	0.195-1.510	
Alcohol use	1.018 (0.038)	0.946-1.095	0.984 (0.051)	0.889-1.090	0.945 (0.113)	0.956-14.286	1.025 (0.066)	0.904-1.162	1.054 (0.068)	0.930-1.195	1.033 (0.086)	0.878-1.215	1.178 (0.194)	0.853-1.626	1.133 (0.145)	0.882-1.456	
CVD status	1.946b (0.548)	1.121-3.380	2.710c (0.912)	1.401-5.239	3.696a (2.550)	0.956-14.286	4.107c (1.607)	1.908-8.841	1.354 (0.412)	0.746-2.460	1.446 (0.524)	0.710-2.944	3.002b (1.665)	1.013-8.902	1.889 (0.993)	0.674-5.294	
Insurance	0.506 (0.348)	0.131-1.949	0.891 (0.711)	0.187-4.254			0.709 (0.776)	0.083-6.056	1.736b (0.447)	1.048-2.877	1.699a (0.545)	0.906-3.186	2.864b (1.385)	1.110-7.391	2.906b (1.208)	1.287-6.565	
No. of fruit servings	0.996 (0.015)	0.966-1.026	1.017 (0.019)	0.980-1.054	1.033 (0.039)	0.960-1.112	1.019 (0.023)	0.976-1.065	1.036 (0.065)	0.917-1.171	1.068 (0.085)	0.914-1.249	1.006 (0.169)	0.723-1.399	0.987 (0.134)	0.755-1.289	
No. of vegetable servings	1.009 (0.042)	0.930-1.095	0.966 (0.052)	0.868-1.074	0.912 (0.108)	0.723-1.150	0.928 (0.062)	0.814-1.057	0.975 (0.064)	0.856-1.109	0.996 (0.080)	0.850-1.167	0.771 (0.136)	0.545-1.090	0.933 (0.120)	0.725-1.201	
Daily vigorous physical activity	1.056a (0.030)	1.000-1.116	1.031 (0.038)	0.959-1.108	0.967 (0.075)	0.831-1.125	0.949 (0.042)	0.870-1.034	0.968 (0.053)	0.869-1.077	0.944 (0.074)	0.810-1.100	1.135 (0.129)	0.908-1.419	1.108 (0.108)	0.915-1.341	
Household per capita expenditure	1.000c (0.000)	1.000-1.000	1.000a (0.000)	1.000-1.000	1.000 (0.000)	1.000-1.000	1.000b (0.000)	1.000-1.000	1.000 (0.000)	1.000-1.000	1.000 (0.000)	1.000-1.000	1.000 (0.000)	0.999-1.000	1.000 (0.000)	0.999-1.000	
Household size	0.936b (0.028)	0.883-0.991	0.946 (0.036)	0.877-1.020	0.926 (0.068)	0.802-1.068	0.921a (0.043)	0.841-1.010	0.986 (0.048)	0.896-1.086	1.015 (0.067)	0.892-1.155	1.022 (0.108)	0.831-1.257	1.070 (0.087)	0.913-1.255	
Other health conditions	0.999 (0.218)	0.652-1.531	0.862 (0.264)	0.473-1.570	1.736 (1.048)	0.532-5.669	0.629 (0.284)	0.260-1.523	0.381 (0.467)	0.035-4.206	0.059a (0.093)	0.003-1.296	0.004b (0.011)	0.000-0.825	0.002c (0.004)	0.000-0.163	
Constant	0.061c (0.058)	0.009-0.393	0.029c (0.038)	0.002-0.391	0.003a (0.010)	0.000-1.064	0.020a (0.040)	0.000-1.058	0.998 (0.211)	0.660-1.509	0.985 (0.274)	0.571-1.697	1.842 (0.849)	0.747-4.544	1.397 (0.563)	0.634-3.078	
The variance-covariance matrix for the fitted logistic regression was used to derive standard errors and confidence intervals of odds ratios. The reported odds ratios were unadjusted.

Abbreviations: CHE, catastrophic health expenditure; CI, confidence interval; CVD, cardiovascular disease; OR, odds ratio; SE, standard error.

aP < .01.

bP < .05.

cP < .1.

DISCUSSION

Many chronic health conditions like CVD predispose individuals and families to CHE, especially in SSA, where the majority of the countries are still grappling with how to achieve UHC. This study assessed the spillover effects of having CVD on the risks of incurring higher CHE among households in 2 SSA countries, Ghana and South Africa. As such, this study is one of the few in SSA that examined the economic burden of CVD in this way.

As depicted in the sociodemographic background to this study, the average age of the head of households with CVD was higher than that of households without CVD. This finding is supported by previous studies where the incidence of CVD, like other chronic diseases, is reported to increase with age.29 Furthermore, evidence in this study revealed that the number of households covered by health insurance is low in both countries but slightly higher in South Africa than in Ghana. The implication is that there is an overreliance on OOP payments for medical care in the 2 countries, which may result in enormous financial hardship for individuals and households. A study reviewing the challenges of mobilizing substantial financial resources to achieve UHC in SSA showed that OOP spending remains the largest source of finance for healthcare services in the region, accounting for approximately 36% of current medical expenditure, which is very high relative to the global average of 22%.30

Likewise, the low access to health insurance reported among households in this study is reflected in the share of household medical spending in total expenditure. In Ghana, households on average spent as much as 12% of total nonfood expenditure on healthcare services. However, in South Africa, the share of medical expenditure in total nonfood spending was only 3%. More importantly, the share of medical expenditure in total household expenditure was revealed to be higher among households with CVD in both countries and across all the considered thresholds, relative to households without CVD. This finding is intuitive since chronic diseases like CVD require regular demand for healthcare services; consequently, this will lead to a larger portion of household resources devoted to accessing medical services. Earlier studies have also published findings that corroborate this evidence. In 2007, a study applied rigorous econometric modeling to investigate the economic burden of CVD in the United States. The study found that almost 30% of all medical spending among major health insurers was due to claims related to CVD treatment.31 Another study in the same country examined the disproportional health spending associated with various health conditions among the elderly. The study reported that the average medical outlay of older persons with chronic health conditions was 5 times greater than those without chronic disease.32 In particular, the study showed that expenditure for treating CVD was the highest among all chronic disease conditions. In SSA, a study on the pattern of chronic disease conditions and the self-reported financial situation of the elderly in South Africa revealed that having chronic disease was associated with household economic conditions.33

Moreover, the risk of incurring CHE increases with a higher economic burden of health expenditure due to increase in the demand for medical services, which is often triggered by the presence of chronic disease conditions in families. This can be seen in the level of CHE experienced among households with regard to their CVD status in this study. Evidence in Ghana and South Africa showed that the extent of CHE incurred in households with CVD was higher compared with that incurred in households without this health condition. Comparing results in both countries, CHE head count was disproportionately higher in Ghana relative to South Africa and this can be as a result of the higher access to health insurance in South Africa as revealed earlier. This suggests that Ghana and South Africa as well as other similar SSA countries need to do more to financially protect their populations to forestall the catastrophic impacts of health expenditure in the event of unanticipated health disruptions. In addition, the result in this study revealed that the difference in CHE incurred among households with a member(s) with CVD and households without persons suffering from CVD, was significantly different as shown in the t-test result. In the model fitted for CHE, the presence of CVD was associated with whether a household experienced CVD in Ghana across the 4 thresholds considered, whereas the effect of CVD was found significant only at the 25% threshold in South Africa. Similarly, this finding is consistent with the evidence reported in previous studies. For instance, a research conducted in China to evaluate the inequality in the experience of CHE induced by having a household member(s) with hypertension revealed that such households incurred a disconcerting level of CHE compared with families with no chronic conditions.34 In 2019, Haakenstad et al35 implemented a cross-country analysis to examine the disease-specific differentials in the incidence of CHE in many countries of the world. Their results showed that heart-related health conditions were associated with about a 1.9% increase in CHE and that this link was stronger compared with other diseases assessed. Overall, much more needs to be done to protect households from the impoverishing effects of excessive health expenditure in both countries and in other similar countries in SSA.

Limitations

Because the majority of SSA countries are data poor, this study was limited by data availability. First, the survey utilized for this study was conducted just over 10 years ago, although a preliminary literature search showed that progress has been slow, as evidenced in the persistently low coverage of health insurance in many countries in SSA. However, the data set remains the most comprehensive and reliable source of data for this type of analysis to date. The data used for this study allowed the study to provide evidence-based information that will be useful in the design of healthcare financing policies among the countries in SSA. Nonetheless, future studies will benefit from regular surveillance of the disease-specific burden of OOP health expenditure among households in SSA. These limitations should be considered when interpreting the findings presented in this study.

CONCLUSION

Research evidence abounds on the increase in the prevalence of CVDs in SSA, imposing substantial economic burdens on individuals and households in the region. One way to evaluate the economic burden of diseases at a microeconomic level is to assess the risk of CHE associated with the disease condition. This study found evidence that suggests that CVD predisposes households to the risk of higher CHE in SSA. Equity in health financing presupposes that access to health insurance should be predicated on individual health needs. Therefore, findings in this study emphasize the need to target and prioritize the health needs of individuals with regard to healthcare financing interventions. Furthermore, governments in Ghana and South Africa, including other countries in SSA, should intensify efforts to fully adopt and effectively implement the WHO’s Global Action Plan for the Prevention and Control of Non-Communicable Diseases. This will certainly facilitate the prevention and control of CHE related to CVDs in the region. Some of the “best buys” policy interventions recommended for curtailing chronic noncommunicable diseases include the control of tobacco use, excessive/unhealthy alcohol intake, reduction in the consumption of sugar-sweetened beverages, and health education to prevent sedentary lifestyle, among other recommendations.36–38 In terms of the consumption of tobacco, excessive alcohol intake and the consumption of sugar-sweetened beverages, governments can adopt highly effective tools such as regular increase in the excise taxes levied on those commodities in addition to the use of other economic and legislative tools.36

Author Contributions

F.I.P.A. and T.A.O. participated in the conception of the study. F.I.P.A. wrote the first draft of the manuscript, and it was reviewed and corrected by T.A.O. Both authors approved the final version of the manuscript.

Disclosures

The authors report no potential conflicts of interest.

Ethics Approval and Consent

This paper used data from the WHO Study on Global AGEing and Adult Health (SAGE) implemented by the World Health Organization ICF in conjunction with the participating countries. Ethical approval for the study was obtained from the World Health Organization’s Ethical Review Board and from each site’s respective ethical board.

Data Availability

The data set used for this study is available based on request through the WHO Multi-Country Studies Data Archive (https://apps.who.int/healthinfo/systems/surveydata/index.php/catalog).

Acknowledgments

We thank the World Health Organization for granting us the license to use the data, without which this study would not have been possible.
==== Refs
Cardiovascular diseases (CVDs) World Health Organization 2017
2019-7-29 https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Accessed July 29, 2019.
Classification of cardiovascular disease Neuropsychology of Cardiovascular Disease Katzel L I Waldstein S R Psychology Press 1 1 2001
19 30
Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions Internal and Emergency Medicine Cappuccio Francesco Paolo Miller Michelle Avril 21 3 2016
11 3 299 305 1828-0447 10.1007/s11739-016-1423-9 10.1007/s11739-016-1423-9 27001886
Committee on Preventing the Global Epidemic of Cardiovascular Disease: meeting the challenges in developing countries Fuster V. Kelly B.B. 2010

Reducing the growing burden of cardiovascular disease in the developing world Health Affairs Gaziano Thomas A. 1 2007
26 1 13 24 0278-2715 10.1377/hlthaff.26.1.13 10.1377/hlthaff.26.1.13 17211010
The global burden of cardiovascular diseases and risks: a compass for global action Journal of the American College of Cardiology Roth Gregory A. Mensah George A. Fuster Valentin 12 2020
76 25 2980 2981 0735-1097 10.1016/j.jacc.2020.11.021 10.1016/j.jacc.2020.11.021
A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries PLoS One Huffman Mark D. Rao Krishna D. Pichon-Riviere Andres Zhao Dong Harikrishnan S. Ramaiya Kaushik Ajay V. S. Goenka Shifalika Calcagno Juan I. Caporale Joaquín E. Niu Shaoli Li Yan Liu Jing Thankappan K. R. Daivadanam Meena van Esch Jan Murphy Adrianna Moran Andrew E. Gaziano Thomas A. Suhrcke Marc Reddy K. Srinath Leeder Stephen Prabhakaran Dorairaj 14 6 2011
6 6 e20821 1932-6203 10.1371/journal.pone.0020821 10.1371/journal.pone.0020821 21695127
Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific BMC Public Health Win Tin Si Thu Kubuabola Ilisapeci Ravuvu Amerita Snowdon Wendy Durand A. Mark Vivili Paula Passmore Erin 12 5 2020
20 1 660 1471-2458 10.1186/s12889-020-08795-2 10.1186/s12889-020-08795-2 32398159
Global burden of cardiovascular diseases and risks collaboration, 1990-2021 Journal of the American College of Cardiology Lindstrom Megan DeCleene Nicole Dorsey Henry Fuster Valentin Johnson Catherine O. LeGrand Kate E. Mensah George A. Razo Christian Stark Benjamin Varieur Turco Justine Roth Gregory A. 12 2022
80 25 2372 2425 0735-1097 10.1016/j.jacc.2022.11.001 10.1016/j.jacc.2022.11.001
Cardiovascular disease in sub-Saharan Africa SA Heart Ntusi Ntobeko 10 2021
18 2 2071-4602 10.24170/18-2-4877 10.24170/18-2-4877
World Heart Day 2022: sub-Saharan Africa—the underserved continent when it comes to cardiovascular disease care 2022
2023-2-4 https://www.pcronline.com/News/Whats-new-on-PCRonline/2022/Sub-Saharan-Africa-underserved-continent-cardiovascular-disease-care Accessed February 4, 2023.
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study The Lancet O'Donnell Martin J Chin Siu Lim Rangarajan Sumathy Xavier Denis Liu Lisheng Zhang Hongye Rao-Melacini Purnima Zhang Xiaohe Pais Prem Agapay Steven Lopez-Jaramillo Patricio Damasceno Albertino Langhorne Peter McQueen Matthew J Rosengren Annika Dehghan Mahshid Hankey Graeme J Dans Antonio L Elsayed Ahmed Avezum Alvaro Mondo Charles Diener Hans-Christoph Ryglewicz Danuta Czlonkowska Anna Pogosova Nana Weimar Christian Iqbal Romaina Diaz Rafael Yusoff Khalid Yusufali Afzalhussein Oguz Aytekin Wang Xingyu Penaherrera Ernesto Lanas Fernando Ogah Okechukwu S Ogunniyi Adesola Iversen Helle K Malaga German Rumboldt Zvonko Oveisgharan Shahram Al Hussain Fawaz Magazi Daliwonga Nilanont Yongchai Ferguson John Pare Guillaume Yusuf Salim 8 2016
388 10046 761 775 0140-6736 10.1016/s0140-6736(16)30506-2 10.1016/s0140-6736(16)30506-2
Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study Circulation Steyn Krisela Sliwa Karen Hawken Steven Commerford Patrick Onen Churchill Damasceno Albertino Ounpuu Stephanie Yusuf Salim 6 12 2005
112 23 3554 3561 0009-7322 10.1161/circulationaha.105.563452 10.1161/circulationaha.105.563452
The burden of non-communicable diseases in South Africa The Lancet Mayosi Bongani M Flisher Alan J Lalloo Umesh G Sitas Freddy Tollman Stephen M Bradshaw Debbie 9 2009
374 9693 934 947 0140-6736 10.1016/s0140-6736(09)61087-4 10.1016/s0140-6736(09)61087-4
An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective Globalization and Health BeLue Rhonda Okoror Titilayo A Iwelunmor Juliet Taylor Kelly D Degboe Arnold N Agyemang Charles Ogedegbe Gbenga 22 9 2009
5 1 10 1744-8603 10.1186/1744-8603-5-10 10.1186/1744-8603-5-10 19772644
Noncommunicable diseases country profiles World Health Organization 2014

Ghana Institute for Health Metrics and Evaluation 2019
2019-3-25 https://www.healthdata.org/ghana Accessed March 25, 2019.
Mortality trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease Study The Lancet Global Health Pillay-van Wyk Victoria Msemburi William Laubscher Ria Dorrington Rob E Groenewald Pam Glass Tracy Nojilana Beatrice Joubert Jané D Matzopoulos Richard Prinsloo Megan Nannan Nadine Gwebushe Nomonde Vos Theo Somdyala Nontuthuzelo Sithole Nomfuneko Neethling Ian Nicol Edward Rossouw Anastasia Bradshaw Debbie 9 2016
4 9 e642 e653 2214-109X 10.1016/s2214-109x(16)30113-9 10.1016/s2214-109x(16)30113-9
Public financing of health in developing countries: a cross-national systematic analysis Lancet Schneider M.T. Gubbins P. Leach-Kemon K.. 2010
375 1375 1387 10.1016/S0140 10.1016/S0140 20381856
Catastrophic health expenditure in sub-Saharan Africa: systematic review and meta-analysis Bulletin of the World Health Organization Eze Paul Osaheni Lawani Lucky Justina Agu Ujunwa Acharya Yubraj 1 5 2022
100 5 337 351J 0042-9686 10.2471/blt.21.287673 10.2471/blt.21.287673 35521041
A comparative cross-sectional study of the prevalence and determinants of health insurance coverage in Nigeria and South Africa: a multi-country analysis of demographic health surveys International Journal of Environmental Research and Public Health Akokuwebe Monica Ewomazino Idemudia Erhabor Sunday 4 2 2022
19 3 1766 1660-4601 10.3390/ijerph19031766 10.3390/ijerph19031766 35162789
Implementation of the National Health Insurance Scheme (NHIS) in Ghana: lessons for South Africa and low-and middle-income countries Risk Manag Healthc Policy Christmals C Aidam K 2021
13 1879 1904 1179-1594 10.2147/RMHP.S245615
Out-of-pocket payments for health care under the National Health Insurance Scheme in Ghana: what do insured clients pay for? Akweongo Patricia Aikins Moses Wyss Kaspar Salari Paola Tediosi Fabrizio 5 1 2021
10.21203/rs.3.rs-133141/v1 10.21203/rs.3.rs-133141/v1
Measuring household welfare: short versus long consumption modules Moratti M. Natali L. 2012

Measuring the catastrophic and impoverishing effect of household health care spending in Serbia Social Science & Medicine Arsenijevic Jelena Pavlova Milena Groot Wim 2 2013
78 1 17 25 0277-9536 10.1016/j.socscimed.2012.11.014 10.1016/j.socscimed.2012.11.014
Incidence, socio-economic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals in Tshwane International Journal for Equity in Health Mutyambizi Chipo Pavlova Milena Hongoro Charles Booysen Frederik Groot Wim 22 5 2019
18 1 1 15 1475-9276 10.1186/s12939-019-0977-3 10.1186/s12939-019-0977-3 31118033
The combined effect on survival of four main behavioural risk factors for non-communicable diseases Preventive Medicine Martin-Diener Eva Meyer Julia Braun Julia Tarnutzer Silvan Faeh David Rohrmann Sabine Martin Brian W. 8 2014
65 148 152 0091-7435 10.1016/j.ypmed.2014.05.023 10.1016/j.ypmed.2014.05.023 24989976
Economic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases in Russia in 2016 Cardiovascular Therapy and Prevention Kontsevaya A. V. Mukaneeva D. K. Myrzamatova A. O. Balanova Yu. A. Khudyakov M. B. Drapkina O. M. 2019
19 1 48 55 2619-0125 10.15829/1728-8800-2020-1-48-55 10.15829/1728-8800-2020-1-48-55
The global burden of cardiovascular diseases and risk factors: 2020 and beyond Journal of the American College of Cardiology Mensah George A. Roth Gregory A. Fuster Valentin 11 2019
74 20 2529 2532 0735-1097 10.1016/j.jacc.2019.10.009 10.1016/j.jacc.2019.10.009
Challenges in financing universal health coverage in sub-Saharan Africa Oxford Research Encyclopedia of Economics and Finance McIntyre Diane Obse Amarech G. Barasa Edwine W. Ataguba John E. 24 5 2018
10.1093/acrefore/9780190625979.013.28 10.1093/acrefore/9780190625979.013.28
The economic burden of chronic cardiovascular disease for major insurers Health Promotion Practice Trogdon Justin G. Finkelstein Eric A. Nwaise Isaac A. Tangka Florence K. Orenstein Diane 7 2007
8 3 234 242 1524-8399 10.1177/1524839907303794 10.1177/1524839907303794 17606951
The prevalence of chronic conditions and medical expenditures of the elderly by chronic condition indicator (CCI) Archives of Gerontology and Geriatrics Chi M J Lee C Y Wu S C 5 2011
52 3 284 289 0167-4943 10.1016/j.archger.2010.04.017 10.1016/j.archger.2010.04.017 20452688
Chronic disease profile, health utilization and self-reported financial situation of older people in rural South Africa International Journal of Aging Research Adeniji Folashayo 2019
13;2(5).5 1 15 2637-3742 10.28933/ijoar-2019-09-2405 10.28933/ijoar-2019-09-2405
Catastrophic healthcare expenditure and its inequality for households with hypertension: evidence from the rural areas of Shaanxi Province in China International Journal for Equity in Health Si Yafei Zhou Zhongliang Su Min Ma Meng Xu Yongjian Heitner Jesse 1 7 2017
16 1 27 1475-9276 10.1186/s12939-016-0506-6 10.1186/s12939-016-0506-6 28666448
Disaggregating catastrophic health expenditure by disease area: cross-country estimates based on the World Health Surveys BMC Medicine Haakenstad Annie Coates Matthew Marx Andrew Bukhman Gene Verguet Stéphane 13 2 2019
17 1 36 1741-7015 10.1186/s12916-019-1266-0 10.1186/s12916-019-1266-0 30755209
Are WHO “best buys” for non-communicable diseases effective in low-income and lower-middle-income countries? A systematic review The Lancet Global Health Allen Luke N Pullar Jessie Wickramasinghe Kremlin Williams Julianne Foster Charlie Roberts Nia Mikkelsen Bente Varghese Cherian Townsend Nick 4 2017
5 S17 2214-109X 10.1016/s2214-109x(17)30124-9 10.1016/s2214-109x(17)30124-9
Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries The Lancet Global Health Allen Luke N Nicholson Brian D Yeung Beatrice Y T Goiana-da-Silva Francisco 1 2020
8 1 e50 e58 2214-109X 10.1016/s2214-109x(19)30446-2 10.1016/s2214-109x(19)30446-2 31813787
Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran BMC Public Health Bakhtiari Ahad Takian Amirhossein Majdzadeh Reza Haghdoost Ali Akbar 14 3 2020
20 1 1 6 1471-2458 10.1186/s12889-020-8446-x 10.1186/s12889-020-8446-x 32171267
